IVF After 40 in Los Angeles: Realistic Expectations and Options
If you're considering IVF after 40 in Los Angeles, the most useful starting point isn't a general timeline — it's an individual evaluation of your ovarian reserve, since fertility after 40 varies significantly from person to person. This guide walks through what tends to change with age, the treatment options typically discussed at this stage, and where an emerging option like PRP ovarian rejuvenation currently stands in terms of evidence.
Key Takeaways
- Fertility after 40 is shaped primarily by egg quantity and quality, both of which decline with age — but the rate and degree of decline varies significantly from person to person, so individual testing matters more than age alone.
- Diminished ovarian reserve (DOR) is common after 40, though not universal, and is assessed through hormone testing and ultrasound rather than age alone.
- Treatment options typically discussed after 40 include conventional IVF, mild-stimulation (mini-IVF) protocols, and donor egg IVF, depending on ovarian reserve testing results.
- PRP ovarian rejuvenation is an emerging treatment still being studied — reproductive medicine organizations, including ASRM, currently consider it investigational, with evidence still developing rather than an established, proven therapy.
- A fertility evaluation — not a general guide — is the only reliable way to understand what a realistic treatment plan looks like for your specific situation.
Key Terms to Know
- Diminished ovarian reserve (DOR): A lower-than-typical quantity of remaining eggs for a given age, assessed through hormone testing (such as AMH) and ultrasound antral follicle counts.
- Advanced maternal age: A clinical term generally referring to pregnancy or fertility treatment at age 35 or older, associated with a natural decline in egg quantity and quality over time.
- AMH (anti-Müllerian hormone): A hormone measured through a blood test that's commonly used as one indicator of ovarian reserve.
- PRP (platelet-rich plasma) ovarian rejuvenation: An investigational procedure involving injection of a concentrated preparation of a patient's own blood platelets into the ovaries, being studied for a possible effect on ovarian function; current evidence is limited and it is not considered an established, proven therapy by major reproductive medicine organizations.
- Donor egg IVF: An IVF cycle using eggs from a donor rather than the patient's own eggs, typically considered when ovarian reserve or egg quality is significantly reduced.
What Changes With Fertility After 40
Fertility after 40 is shaped mainly by two factors: the number of eggs remaining (ovarian reserve) and the quality of those eggs, both of which tend to decline with age. This isn't a switch that flips at a specific birthday — it's a gradual pattern that varies significantly between individuals, which is why two women of the same age can have very different ovarian reserve test results.
Because of this variability, general statistics about age and fertility aren't a reliable stand-in for your own testing. Hormone levels, antral follicle count, and your personal medical history give a far more accurate picture of your situation than age alone.

Treatment Options to Discuss With Your Care Team
Several treatment paths are typically discussed for patients over 40, and the right one depends on your individual ovarian reserve testing results.
These options aren't mutually exclusive over time — some patients start with conventional or mild-stimulation IVF using their own eggs and discuss donor egg IVF later if needed, based on how earlier cycles go.

PRP Ovarian Rejuvenation: What the Evidence Currently Shows
PRP ovarian rejuvenation involves injecting a concentrated preparation of a patient's own blood platelets into the ovaries, with the aim of potentially supporting ovarian function. It's an area of active research interest, particularly for patients with diminished ovarian reserve, but it's important to understand where the evidence currently stands before considering it.
Major reproductive medicine organizations, including ASRM, currently describe ovarian rejuvenation techniques like PRP as unproven, and existing research reviews describe the evidence as limited and inconsistent across studies. Some smaller studies have reported changes in ovarian reserve markers following PRP, but this hasn't yet been established as a reliable or predictable treatment effect at a larger scale. This means PRP should be considered an emerging, investigational option rather than a standard or guaranteed part of treatment, and it's worth discussing directly with your care team what the current evidence does and doesn't show before deciding whether it's relevant to your situation.

Mild-Stimulation IVF for Advanced Maternal Age
Mild-stimulation IVF is sometimes specifically considered for patients of advanced maternal age with diminished ovarian reserve, since high-dose stimulation doesn't necessarily retrieve significantly more eggs when ovarian reserve is already low — meaning the added medication cost and physical impact may not offer a proportional benefit. [LINK: mini-ivf-los-angeles]
This is why some clinics, including GenPrime, offer a mild-stimulation program specifically designed for this cohort. The right protocol still depends on individual ovarian reserve testing rather than age alone, so this is a conversation to have directly with your care team rather than a default assumption.

Building a Realistic Treatment Plan
A few questions are worth bringing to your first consultation to help set realistic expectations for your specific situation.
- What do my ovarian reserve test results actually indicate for my situation specifically, rather than for my age group generally?
- Which protocol is being recommended for me, and why — conventional, mild-stimulation, or another approach?
- What would make donor egg IVF a relevant conversation for my specific case, if it becomes one?
- What is currently known and not known about PRP ovarian rejuvenation, if I'm considering it as part of my plan?
- How many cycles might realistically be part of my plan, based on my testing rather than a general estimate?
Bringing these questions to a consultation helps ground your plan in your own testing results rather than general expectations about age. Schedule a consultation

IVF After 40 at GenPrime Fertility
Yes — GenPrime Fertility offers treatment options relevant to patients over 40 at our Anaheim clinic, including conventional IVF, a mild-stimulation program for advanced maternal age, and PRP ovarian rejuvenation as an option to discuss directly with your care team. [LINK: schedule-a-consultation-anaheim]
Every care plan starts with ovarian reserve testing and a review of your medical history, so your recommended protocol is based on your specific results rather than a standard approach applied to everyone in a given age range.

FAQ Section
1. Is IVF after 40 different from IVF at a younger age?
The clinical steps are the same, but the protocol recommended — and the role of ovarian reserve testing in that decision — often differs, since egg quantity and quality typically decline with age.
2. What is diminished ovarian reserve?
Diminished ovarian reserve (DOR) means a lower-than-typical quantity of remaining eggs for a given age, assessed through hormone testing and ultrasound rather than age alone.
3. Does PRP ovarian rejuvenation work?
Current evidence is limited and inconsistent. Major reproductive medicine organizations, including ASRM, currently describe ovarian rejuvenation techniques like PRP as unproven and still under study, not an established treatment.
4. Is mild-stimulation IVF better than conventional IVF after 40?
Neither is inherently better — the right protocol depends on your individual ovarian reserve testing. Mild-stimulation is sometimes considered when high-dose stimulation is unlikely to significantly increase egg yield.
5. When is donor egg IVF discussed for patients over 40?
This is typically discussed when ovarian reserve or egg quality testing suggests it may be a relevant option, or after previous cycles using a patient's own eggs haven't resulted in usable embryos.
6. Does GenPrime Fertility offer treatment options for patients over 40?
Yes. GenPrime offers conventional IVF, a mild-stimulation program for advanced maternal age, and PRP ovarian rejuvenation as an option to discuss with your care team. [LINK: schedule-a-consultation-anaheim]
Related Questions
Can I improve my ovarian reserve before starting treatment?
Ovarian reserve is not something that can be meaningfully increased once established, though your care team can advise on general health factors worth addressing before starting treatment.
Does age affect embryo testing recommendations?
Some patients over 40 discuss genetic testing of embryos (PGT-A) with their care team, since chromosomal abnormalities become more common with age, though this is an individual decision.
How is ovarian reserve tested?
Ovarian reserve is typically assessed through an AMH blood test and an antral follicle count via ultrasound, usually done early in the evaluation process.
Is age alone a reason to be told IVF won't work?
No single test or age cutoff can predict an individual outcome. A full evaluation of your specific testing results is needed before any realistic expectations can be discussed.
This article is for informational purposes only and does not constitute medical advice. Individual outcomes vary based on ovarian reserve, age, and medical history. PRP ovarian rejuvenation is considered investigational by major reproductive medicine organizations, and evidence of its effectiveness is still developing. Consult a licensed fertility specialist to discuss what's appropriate for your specific situation.
Sources: American Society for Reproductive Medicine (ASRM) patient and practice guidance on ovarian aging and ovarian rejuvenation techniques; peer-reviewed systematic reviews on platelet-rich plasma in reproductive medicine.

